An app has launched in Germany which lets users scan their body to test for signs of skin cancer.
Digital health company SkinVision has teamed up with health insurer Central to provide the app to policyholders, which can use it to scan for the first signs of skin cancer.
The app uses a clinically tested algorithm which calculates signs of skin cancer in skin spots and surrounding tissue. Once a scan is complete, SkinVision then provides an indication of low, medium or high risk in 30 seconds and lets users know which skin spots they should review over time. If a user receives a high-risk rating, a team of dermatologists offer them advice within 48 hours about the next steps they should take.
SkinVision and Central’s partnership was borne out of the desire to help counteract the rising numbers of skin cancer diagnoses across Europe. The companies hope that the app helps to detect skin cancer earlier for many users.
“With our app, we motivate many users to go to their doctor early in the case of skin changes, ensuring they get there at the right time” says Erik de Heus, CEO of SkinVision. “The service also reduces the costs to the healthcare system. We are very excited about how this partnership will evolve”.
“The use of intelligent technologies is a central component of our Smart Insurance offensive” explains Dr Jochen Petin, chief insurance officer Health of Generali Deutschland AG and CEO of Central Krankenversicherung. “Around two years ago, Generali started its digital transformation with the aim of becoming a reliable partner in all areas of life for its policyholders. We are doing this through the use of innovative solutions, particularly in the area of preventative health, ensuring we reach the customer before they are affected. We do not just want to insure, we want to improve”.